Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.

Shagdarsuren E, Bidzhekov K, Mause SF, Simsekyilmaz S, Polakowski T, Hawlisch H, Gessner JE, Zernecke A, Weber C.

Circulation. 2010 Sep 7;122(10):1026-36. doi: 10.1161/CIRCULATIONAHA.110.954370. Epub 2010 Aug 23.

PMID:
20733098
2.

Complement 5a receptor inhibition improves renal allograft survival.

Gueler F, Rong S, Gwinner W, Mengel M, Bröcker V, Schön S, Greten TF, Hawlisch H, Polakowski T, Schnatbaum K, Menne J, Haller H, Shushakova N.

J Am Soc Nephrol. 2008 Dec;19(12):2302-12. doi: 10.1681/ASN.2007111267. Epub 2008 Aug 27.

3.

Complement C5 mediates experimental tubulointerstitial fibrosis.

Boor P, Konieczny A, Villa L, Schult AL, Bücher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T.

J Am Soc Nephrol. 2007 May;18(5):1508-15. Epub 2007 Mar 27.

4.

Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity.

Schnatbaum K, Locardi E, Scharn D, Richter U, Hawlisch H, Knolle J, Polakowski T.

Bioorg Med Chem Lett. 2006 Oct 1;16(19):5088-92. Epub 2006 Jul 28.

PMID:
16876401
5.

A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.

Köhl J, Baelder R, Lewkowich IP, Pandey MK, Hawlisch H, Wang L, Best J, Herman NS, Sproles AA, Zwirner J, Whitsett JA, Gerard C, Sfyroera G, Lambris JD, Wills-Karp M.

J Clin Invest. 2006 Mar;116(3):783-96.

6.

Complement and Toll-like receptors: key regulators of adaptive immune responses.

Hawlisch H, Köhl J.

Mol Immunol. 2006 Jan;43(1-2):13-21. Review.

PMID:
16019071
7.

C5a negatively regulates toll-like receptor 4-induced immune responses.

Hawlisch H, Belkaid Y, Baelder R, Hildeman D, Gerard C, Köhl J.

Immunity. 2005 Apr;22(4):415-26.

8.

C5a initiates the inflammatory cascade in immune complex peritonitis.

Godau J, Heller T, Hawlisch H, Trappe M, Howells E, Best J, Zwirner J, Verbeek JS, Hogarth PM, Gerard C, Van Rooijen N, Klos A, Gessner JE, Köhl J.

J Immunol. 2004 Sep 1;173(5):3437-45.

9.

The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.

Hawlisch H, Wills-Karp M, Karp CL, Köhl J.

Mol Immunol. 2004 Jun;41(2-3):123-31. Review.

PMID:
15159057
10.

C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.

Otto M, Hawlisch H, Monk PN, Müller M, Klos A, Karp CL, Köhl J.

J Biol Chem. 2004 Jan 2;279(1):142-51. Epub 2003 Oct 21.

11.

Site-specific anti-C3a receptor single-chain antibodies selected by differential panning on cellulose sheets.

Hawlisch H, Müller M, Frank R, Bautsch W, Klos A, Köhl J.

Anal Biochem. 2001 Jun 1;293(1):142-5. No abstract available.

PMID:
11373092
12.

Guinea pig C3 specific rabbit single chain Fv antibodies from bone marrow, spleen and blood derived phage libraries.

Hawlisch H, Meyer zu Vilsendorf A, Bautsch W, Klos A, Köhl J.

J Immunol Methods. 2000 Mar 6;236(1-2):117-31.

PMID:
10699585
13.

Selection of phage-displayed anti-guinea pig C5 or C5a antibodies and their application in xenotransplantation.

Link C, Hawlisch H, Meyer zu Vilsendorf A, Gylerüz S, Nagel E, Köhl J.

Mol Immunol. 1999 Dec;36(18):1235-47.

PMID:
10684963
14.

Site-directed C3a receptor antibodies from phage display libraries.

Hawlisch H, Frank R, Hennecke M, Baensch M, Sohns B, Arseniev L, Bautsch W, Kola A, Klos A, Köhl J.

J Immunol. 1998 Mar 15;160(6):2947-58.

Supplemental Content

Loading ...
Support Center